Page last updated: 2024-11-05

thalidomide and Bone Inflammation

thalidomide has been researched along with Bone Inflammation in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Takama, H1
Ando, Y1
Yanagishita, T1
Ohshima, Y1
Akiyama, M1
Watanabe, D1
Kikuchi, N1
Yamamoto, T1

Other Studies

2 other studies available for thalidomide and Bone Inflammation

ArticleYear
Successful treatment of pustulotic arthro-osteitis with apremilast: a case report with follow-up MRI.
    European journal of dermatology : EJD, 2019, 12-01, Volume: 29, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Female; Follow-Up Studies; Humans; Magneti

2019
Effects of apremilast on pustulotic arthro-osteitis in a real-world setting: Report of five cases.
    Dermatologic therapy, 2020, Volume: 33, Issue:2

    Topics: Arthritis; Humans; Osteitis; Psoriasis; Thalidomide

2020